Your browser doesn't support javascript.
SARS-CoV-2 dilated cardiomyopathy.
Cáceres-Acosta, Manuel Felipe; Idrobo, Bairon Díaz; Urbano Albán, Diana Carolina.
  • Cáceres-Acosta MF; Cardiologist, Cardiovascular Line of the Health Research Group (GIS) and Postgraduate Professor, University of Cauca Hospital Universitario San José, Carrera 6 #10N-142, 190002 Popayán, Cauca, Colombia.
  • Idrobo BD; General Practitioner Hospital Universitario San José, Carrera 6 #10N-142, 190002 Popayán, Cauca, Colombia.
  • Urbano Albán DC; General Practitioner Hospital Universitario San José, Carrera 6 #10N-142, 190002 Popayán, Cauca, Colombia.
Br J Cardiol ; 29(3): 30, 2022.
Article in English | MEDLINE | ID: covidwho-2253461
ABSTRACT
SARS-CoV-2 is an emerging cause of viral myocarditis that generates multiple complications, such as dilated cardiomyopathy. We describe a young, obese male patient with severe myocardial involvement by the SARS-CoV-2 virus, who presented with chest pain, elevated cardiac enzymes, non-specific electrocardiographic findings, echocardiogram with evidence of dilated heart disease with reduced ejection fraction, and subsequent verification using magnetic resonance imaging (MRI). The results of the cardiac MRI were typical of viral myocarditis. The patient did not respond to a short course of systemic steroids and the standard management for heart failure, had multiple re-admissions, and, unfortunately, died.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Br J Cardiol Year: 2022 Document Type: Article Affiliation country: Bjc.2022.030

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Br J Cardiol Year: 2022 Document Type: Article Affiliation country: Bjc.2022.030